Skip to main content
. 2020 Sep 22;11(6):1535–1547. doi: 10.1002/jcsm.12532

Table 3.

Monthly change in secondary and exploratory physical function and nutritional outcome variables in the modified intention‐to‐treat population (patients assessed at discharge)

Endpoint

Control formula

Within‐group change (N = 63)

Experimental formula

Within‐group change (N = 64)

Treatment effect

Between‐group difference a

P‐value
Secondary outcome variables
MMSE (score) −0.11 (−0.16 to −0.05) a 0.46 (0.25 to 0.66) a 0.57 (0.352 to 0.773) <0.001
Trail making test (s) −0.12 (−0.48 to 0.23) −3.32 (−4.01 to −2.63) a −3.20 (−3.97 to −2.43) <0.001
Barthel index (score) 0.92 (−0.15 to 1.99) 5.02 (3.77 to 6.27) a 4.10 (2.47 to 5.73) <0.001
Activities of daily living (score) 0.01 (−0.10 to 0.12) 0.67 (0.51 to 0.83) a 0.66 (0.46 to 0.85) <0.001
Tinetti scale (score) −0.27 (−0.57 to 0.03) 2.09 (1.67 to 2.52) a 2.36 (1.85 to 2.88) <0.001
Body weight (kg) −0.90 (−1.09 to −0.70) a 1.55 (1.35 to 1.76) a 2.45 (2.17 to 2.73) <0.001
Handgrip strength (kg) −1.47 (−2.01 to −0.92) a 3.98 (3.20 to 4.75) a 5.45 (4.51 to 6.38) <0.001
SF‐12 PCS (score) 0.16 (−1.09 to 1.40) 1.47 (0.68 to 2.26) a 1.31 (−0.15 to 2.77) 0.08
SF‐12 MCS (score) 1.38 (0.61 to 2.16) a 1.25 (0.28 to 2.222) a −0.13 (−1.367 to 1.098) 0.82
Appendicular muscle mass (g) −69.4 (−843.7 to 704.9) 949.8 (783.7 to 1115.8) a 1019.2 (235.2 to 1803.2) 0.011
Skeletal muscle mass index (kg/m2) −0.02 (−0.35 to 0.32) 0.38 (0.31 to 0.442) a 0.40 (0.06 to 0.73) 0.023
SPPB (score) 0.33 (0.19 to 0.46) a 2.60 (2.23 to 2.98) a 2.27 (1.88 to 2.68) <0.001
Chair stand test (s) −4.44 (−5.85 to −3.03) a 8.20 (7.05 to 9.35) a 12.64 (10.84 to 14.44) <0.001
Timed up and go test (s) −0.76 (−1.07 to −0.44) a 2.95 (2.41 to 3.49) a 3.71 (3.09 to 4.33) <0.001
Exploratory outcome variables
Protein intake (g/day) 4.70 (3.68 to 5.71) a 17.18 (15.96 to 18.41) a 12.48 (10.91 to 14.06) <0.001
Energy intake (kcal/day) 129.2 (123.6 to 134.8) a 182.3 (167.9 to 196. 8) a 53.1 (37.8 to 68.5) <0.001
Mini Nutritional Assessment (score) 0.36 (0.04 to 0.68) a 1.88 (1.48 to 2.27) a 1.52 (1.02 to 2.02) <0.001
C‐reactive protein (mg/dL) 0.05 (−0.11 to 0.21) −0.38 (−0.58 to −0.19) a 0.43 (0.18 to 0.68) <0.001
25‐hydroxyvitamin D (ng/mL) 0.09 (−0.64 to 0.83) 6.70 (5.26 to 8.14) a 6.61 (5.00 to 8.21) <0.001
Total cholesterol (mg/dL) −2.87 (−6.82 to 1.07) 1.87 (−2.70 to 6.43) 4.74 (−1.24 to 10.71) 0.12
Albumin (g/dL) −0.14 (−0.21 to −0.07) a 0.20 (0.15 to 0.25) a 0.34 (0.25 to 0.43) <0.001
Creatinine (mg/dL) −0.01 (−0.03 to 0.01) 0.02 (0.00 to 0.05) a 0.03 (0.00 to 0.06) 0.031

Data are provided as mean and 95%CI.

Abbreviations: MMSE, Mini Mental State Examination; SF‐12 MCS, 12‐item Short Form General Health Survey‐Mental Component Summary; SF‐12 PCS, 12‐item Short Form General Health Survey‐Physical Component Summary; SPPB, Short Physical Performance Battery.

a

Within‐group change significant at the 5% level.